The Impact of Weight-Loss Drugs on the Substance Use Disorder (SUD) Treatment Industry
Weight-loss medications like Ozempic and Wegovy, which were originally developed for the treatment of diabetes, have become a sensation in recent years as effective...
Navigating the Growing Pains of Behavioral Health: Weathering the Storm and Building Stronger Partnerships
The Behavioral Health Industry Growth has been one of the most significant shifts in healthcare in recent years. While the industry is still relatively...
The Growing Impact of Behavioral Health Value-Based Care: A Shift Away from Traditional Fee-for-Service Models
Traditional fee-for-service reimbursement arrangements have long been the backbone of the U.S. healthcare system. However, there is increasing evidence that these models may be...
Pelago Appoints Frank Jennings as New President to Lead the Future of Virtual Substance Use Management
Pelago, a trailblazer in virtual substance use management, has recently announced the appointment of Frank Jennings as its new president. With an impressive background...
The Importance of Medication-Assisted Treatment for Opioid Use Disorder: Why Non-Opioid Options May Not Be Enough
Medication-assisted treatment (MAT) has long been recognized as the gold standard in treating opioid use disorder (OUD). Medications such as methadone and buprenorphine, both...
Jimini Raises $8 Million in Pre-Seed Funding to Revolutionize Therapy with AI Assistance
In a groundbreaking move for the digital health space, Jimini, an AI-backed therapy platform, has secured $8 million in pre-seed funding. The New York-based...
